Dow Up 2.00% Nasdaq Up 1.66%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
2.92 Up 0.04(1.39%) Feb 12, 4:00PM EST
|After Hours : 2.92 Up 0.00 (0.02%) Feb 12, 5:07PM EST
Prev Close:2.88
Open:2.87
Bid:2.50 x 900
Ask:3.19 x 500
1y Target Est:5.25
Beta:0.660985
Next Earnings Date:22-Feb-16PDLI Earnings announcement
Day's Range:2.86 - 2.96
52wk Range:2.58 - 7.43
Volume:1,163,619
Avg Vol (3m):2,331,350
Market Cap:477.64M
P/E (ttm):1.75
EPS (ttm):1.67
Div & Yield:0.20 (6.85%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PDLIUp 1.39%477.64M
AMGNUp 2.30%109.12B
XOMAUp 0.74%91.88M
SGENUp 5.92%3.99B

Key Statistics

Forward P/E (1 yr):4.17
P/S (ttm):0.95
Ex-Dividend Date:02-Mar-16

Analysts

Annual EPS Est (Dec-15) :1.94
Quarterly EPS Est (Dec-15) :0.54
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback